Establishment Labs (ESTA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
28 May, 2026Opening remarks and agenda
Meeting called to order virtually with all board members and key executives present.
Introduction of directors, CFO, General Counsel, and independent auditors.
Shareholders welcomed and informed about the virtual Q&A process.
Board and executive committee updates
Six directors nominated for election to serve one-year terms.
Shareholder proposals
Three proposals presented: election of directors, advisory vote on executive compensation, and ratification of independent auditors.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Establishment Labs
- Q1 revenue up 45% year-over-year, gross margin at 70.7%, and 2026 guidance raised.ESTA
Q1 20268 May 2026 - Director compensation figures were corrected, and additional equity awards disclosed for consulting roles.ESTAProxy filing24 Apr 2026
- Virtual meeting to elect directors, approve pay, and ratify auditor, with strong governance focus.ESTAProxy filing10 Apr 2026
- Vote on directors, executive pay, and auditor ratification at the May 2026 annual meeting.ESTAProxy filing10 Apr 2026
- Q4 revenue up 45%, gross margin at 70.5%, and 2026 guidance projects 25%+ growth.ESTAQ4 20259 Apr 2026
- Motiva's U.S. growth outpaced expectations, with premium pricing and innovation fueling expansion.ESTATD Cowen 46th Annual Health Care Conference2 Mar 2026
- Q2 revenue rose 18.7% sequentially; FDA approval for Motiva Implants expected soon.ESTAQ2 20242 Feb 2026
- Innovation, global expansion, and regulatory progress position the company for rapid growth.ESTAGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- U.S. approval nears as global expansion and premium product launches drive margin growth.ESTAJefferies Global Healthcare Conference31 Jan 2026